Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab for erosive interphalangeal finger joint osteoarthritis
2006-000925-71Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- Mar 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in erosive hand osteoarthritis (EHOA) comparing Adalimumab arm with Placebo arm (2 arms). Primary endpoint: Remodeling of all erosive joints at 1 year. Started Mar 2006; status: completed.
02
Drugs
03
Conditions
erosive hand osteoarthritis (EHOA)
Beyond the preview
Go deeper on 2006-000925-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000925-71.